Syngene International Limited has acquired its first biologics manufacturing facility in the US to enhance its global capabilities, with increased production capacity of 50,000L for large molecules as of March 10, 2025.
AI Assistant
Syngene International Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.